Synthetic cathinones derivatives may possess both amphetamine-like properties and the ability to modulate serotonin, causing distinct psychoactive effects.) The Drug Enforcement Administration (DEA) eventually banned them after a series of fatalities occurred
To learn more and schedule, call us at (214) 216-1033
Ozempic quickly became one of the most recognized names in diabetes care, while Wegovy opened new conversations in obesity treatment, destigmatizing care and deepening connection with patients worldwide
New FDA policy on compounding GLP-1 drugs New FDA policy on compounding GLP-1 drugs On April 24, 2025, FDA announced that licensed pharmacies and physicians can no longer compound semaglutide (a GLP-1 drug used in Ozempic & Wegovy) and outsourcing facilities must stop production by May 22, 2025
Improve Digestive Health: Glutathione's role in reducing oxidative stress can contribute to improved sleep quality and increased energy levels